"Smoker's paradox" in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Cardiology

• Publication date

  2016-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2016.07.172PMID 27521557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of smoking with myocardial injury and clinical outcome in patients undergoing mechanical reperfusion for ST-elevation myocardial infarction

  2016cited by this paper
• Smoke over myocardial infarction: cigarettes and reperfusion injury.

  2016cited by this paper
• Acute Cardiovascular Care: Intraaortic balloon support for myocardial infarction with cardiogenic shock*

  2016cited by this paper
• Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients. The smoker's paradox revisited by CMR

  2015cited by this paper
• A history of smoking is associated with improved survival in patients treated with mild therapeutic hypothermia following cardiac arrest.

  2014cited by this paper
• Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).

  2014cited by this paper
• 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous

  2014cited by this paper
• 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca

  2014cited by this paper
• Paradoxical Association of Smoking With In‐Hospital Mortality Among Patients Admitted With Acute Ischemic Stroke

  2013cited by this paper
• Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.

  2013cited by this paper
• The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study.

  2013cited by this paper
• Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline.

  2012cited by this paper
• Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.

  2012cited by this paper
• Intraaortic balloon support for myocardial infarction with cardiogenic shock.

  2012cited by this paper
• The "smoker's paradox" in patients with acute coronary syndrome: a systematic review

  2011cited by this paper
• Difference in risk factors between acute coronary syndrome and stable angina pectoris in the Japanese: smoking as a crucial risk factor of acute coronary syndrome.

  2010cited by this paper
• Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective

  2009cited by this paper
• Prediction of One-Year Survival in High-Risk Patients with Acute Coronary Syndromes: Results from the SYNERGY Trial

  2008cited by this paper
• Ten-Year Trends in the Incidence and Treatment of Cardiogenic Shock

  2008cited by this paper
• The etiology of 'smoker's paradox' in acute myocardial infarction with special emphasis on the association with inflammation.

  2008cited by this paper
• Sex differences of risk factors for acute myocardial infarction in Japanese patients.

  2006cited by this paper
• Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction.

  2005cited by this paper
• Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.

  2005cited by this paper
• Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited.

  2005cited by this paper
• Comparison of mortality rates after acute myocardial infarction in smokers versus nonsmokers.

  2004cited by this paper
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

  2004cited by this paper
• Impact of smoking on the incidence and survival of cardiogenic shock complicating acute myocardial infarction treated with reperfusion therapy.

  2002cited by this paper
• Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2).

  2002cited by this paper
• In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the "smoker's paradox" in a countrywide study.

  2001cited by this paper
• Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis.

  1996cited by this paper
• Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey).

  1996cited by this paper
• Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction.

  1995cited by this paper
• How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial)

  1995cited by this paper
• Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded

  1995cited by this paper
• Significance of Smoking in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction Experience Gleaned From the International Tissue Plasminogen Activator/Streptokinase Mortality Trial

  1993cited by this paper
• Effect of Cigarette Smoking on Outcome After Thrombolytic Therapy for Myocardial Infarction

  1991cited by this paper
• Smoking status at the time of acute myocardial infarction and subsequent prognosis.

  1985cited by this paper

• Application of the Updated Cardiogenic Shock Working Group SCAI Classification for Cardiogenic Shock: A Single-Center Analysis.

  2025cites this paper
• Smoking and long-term risks for morbidity and mortality after coronary artery bypass grafting

  2025cites this paper
• Risk factors for cardiogenic shock incidence and mortality after acute myocardial infarction: a systematic review and meta-analysis

  2025cites this paper
• Predictors and Impact of Cardiogenic Shock in Oldest-Old ST-Elevation Myocardial Infarction Patients

  2025cites this paper
• Preoperative smoking status and long-term survival after coronary artery bypass grafting: a competing risk analysis

  2024cites this paper
• Unfolding the reality of the smoking paradox in a South Asian cohort of patients presenting with ST-elevation acute coronary syndrome undergoing primary percutaneous coronary intervention

  2023influential citation
• Leukocyte and its Subtypes as Predictors of Short-Term Outcome in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Cohort Study

  2021cites this paper
• Participation in disease management programs and major adverse cardiac events in patients after acute myocardial infarction: a longitudinal study based on registry data

  2020cites this paper
• Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction

  2019cites this paper
• Assessment of microcirculation in cardiogenic shock.

  2019cites this paper
• Association of Baseline Smoking Status with Long-Term Prognosis in Patients Who Underwent Percutaneous Coronary Intervention: Large Single-Center Data

  2019cites this paper
• Mortalidad hospitalaria de 415.798 pacientes con IAM: 4 años antes en Canarias que en el conjunto de España

  2019cites this paper
• Impact of smoking on all-cause mortality and cardiovascular events in patients after coronary revascularization with a percutaneous coronary intervention or coronary artery bypass graft: a systematic review and meta-analysis

  2019cites this paper
• Hospital Mortality in 415 798 AMI Patients: 4 Years Earlier in the Canary Islands Than in the Rest of Spain.

  2019cites this paper
• Usefulness of the SYNTAX score II to validate 2‐year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single‐center study

  2018cites this paper
• Functional, Cellular, and Molecular Remodeling of the Heart under Influence of Oxidative Cigarette Tobacco Smoke

  2017cites this paper